PCSK9

Gene11 papersHGNC 20001MGI 2140260NCBI Gene 255738Taxon 9606

Humans5
Animals1

Latest

11

American Journal of Preventive CardiologyHumans9 h

Circulating PCSK9 as a sex-stratified predictor in primary prevention of cardiovascular disease: Insights from a prospective cohort study in Chinese adults

Journal of Lipid and AtherosclerosisReview1 Oct

Optimal LDL-C Levels for Ischemic Stroke Prevention: A Neurologist's Perspective

AtherosclerosisHumans30 Sep

Lipoprotein(a) reduction with PCSK9-targeting pharmacotherapy: A prospective real-world registry study

Current Atherosclerosis ReportsReview30 Sep

An Update of Oxidative Stress in Atherosclerosis with Emphasis on the LOX-1-NLRP3 Inflammasome Axis

Archives of Medical ResearchHumans29 Sep

Mexican Registry of Dyslipidemias of the Mexican Institute of Social Security: Lipid Profiles in Patients at High and Very High Cardiovascular Risk

Clinical Research in CardiologyHumans29 Sep

Long-term LDL-C lowering and treatment persistence with inclisiran: 3-year follow-up from the German Inclisiran Network

Oncology LettersHumans28 Sep

Circulating PCSK9: A new frontier in cancer risk stratification for obese diabetics

International Journal of Molecular SciencesReview28 Sep

Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome

The Annals of PharmacotherapyReview26 Sep

Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia

American Journal of Cardiovascular DiseaseReview26 Sep

Residual cardiovascular risk beyond LDL-cholesterol control: what remains unaddressed?